Long-term Progressive Improvement of Atopic Dermatitis by an Herbal Emollient Plus Combination in a 12-week Clinical Trial
Acta Dermato-Venereologica · 2025
DOI: 10.2340/actadv.v105.43026 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Acta Dermato-Venereologica, 2025. Verfasst von Lars Herrmann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Bionorica SE, Neumarkt, Germany. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Emollients, Plant Extracts, Cannabidiol. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Atopic dermatitis is a chronic inflammatory skin disease characterized by flare-ups of inflamed, dry, and itchy skin affecting over 200 million people worldwide. “Emollients plus” containing active cosmetic ingredients such as herbal extracts and phytochemicals have the potential to surpass the efficacy of conventional emollients, while avoiding side effects associated with pharmacological interventions. The reported 12-week clinical trial (NCT05790083) evaluated long-term efficacy and tolerability of oil-in-water emulsions BNO 3731 and BNO 3732 containing ginger extract and cannabidiol as basic emollient therapy for atopic dermatitis. A total of 100 adults and children with a history of atopic dermatitis were included and applied BNO 3732 (body lotion) twice daily and BNO 3731 (intensive care product) as needed. Over 12 weeks the emollients plus combination led to sustained improvement of peak pruritus and patient-reported outcome measures, i.e., “Recap of atopic eczema”. Objective dermatological evaluation showed progressive improvements for vIGA-ADTM and isolated symptoms, i.e., erythema and dryness. Instrumental analysis of intercellular lipid contents and lipid lamellae organization in the stratum corneum demonstrated recovery of the epidermal barrier integrity. The clinical results provide evidence on the efficacy of herbal emollients plus beyond mere moisturizing and occlusive properties. BNO 3731 and BNO 3732 were very well tolerated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bionorica SE, Neumarkt, Germany.
- Microscopy Services Dähnhardt GmbH, Flintbek, Germany.
- Bionorica SE, Neumarkt, Germany. christoph.abels@bionorica.de.
ORCID-Profile: Lars Herrmann, Stanislav Andreev, Christoph Abels
Zitieren
APA
Herrmann, L., Andreev, S., Ziegler, R., Neubauer, C., Moritz, K., Maehler, N., Steindl, H., Daehnhardt-Pfeiffer, S., & Abels, C. (2025). Long-term Progressive Improvement of Atopic Dermatitis by an Herbal Emollient Plus Combination in a 12-week Clinical Trial. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v105.43026
Vancouver
Herrmann L, Andreev S, Ziegler R, Neubauer C, Moritz K, Maehler N, et al. Long-term Progressive Improvement of Atopic Dermatitis by an Herbal Emollient Plus Combination in a 12-week Clinical Trial. Acta Dermato-Venereologica. 2025. doi:10.2340/actadv.v105.43026
BibTeX
@article{Herrmann2025,
author = {Herrmann, Lars and Andreev, Stanislav and Ziegler, Ramona and Neubauer, Christine and Moritz, Kathrin and Maehler, Nicole and Steindl, Hubert and Daehnhardt-Pfeiffer, Stephan and Abels, Christoph},
title = {Long-term Progressive Improvement of Atopic Dermatitis by an Herbal Emollient Plus Combination in a 12-week Clinical Trial},
journal = {Acta Dermato-Venereologica},
year = {2025},
doi = {10.2340/actadv.v105.43026}
}
EUVIMED